University of Calgary-born Parvus Therapeutics has inked an $800m deal with Genentech to develop and commercialise treatments for autoimmune diseases.
UC Riverside has sealed an MOU with incubator Murrieta Genomics to drive its genomics research and build links between the innovation ecosystems of both parties.
The industry-academia partnership will start out with collaborations in the healthcare, robotics and human resources spaces, including a sports science tie-up with a Rakuten-owned baseball team and plans for software development hackathons.
University of Dundee intelligent drug design spinout Exscientia has struck a business deal with Celgene after raising series B funding from the corporate in January.
Hebrew University Jerusalem’s Yissum is tuning up an extension of its overseas commercialisation activities in the US, South America and China.
Kentucky’s public higher education institutions have joined forces for a commercialisation drive part funded by a $1.2m grant from state-run entrepreneurship hub KY Innovation.
The institute has secured grant funding to coalesce its entrepreneurial services into a new centre partnered with corporates including Teva, Rafael Advanced Defense Systems and Alpha Omega.
Kyoto University Innovation Capital is partnering Infinite Capital Holding as part of efforts to let spinouts conduct clinical trials in China.